IMVT Stock-Based Compensation
Immunovant Inc · Stock-Based Compensation
IMVT Stock-Based Compensation
Latest reported$13.77Mperiod ending
IMVT Quarterly Stock-Based Comp ($355.28K → $13.77M)
Quarterly stock-based compensation
High-resolution chart · PNG
IMVT stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 13,774,000 | |
| 11,141,000 | |
| 12,715,000 | |
| 13,358,000 | |
| 18,510,000 | |
| 11,687,000 | |
| 11,652,000 | |
| 12,693,000 | |
| 13,455,000 | |
| 9,679,000 | |
| 10,220,000 | |
| 10,529,000 | |
| 10,688,000 | |
| 7,546,000 | |
| 8,906,000 | |
| 8,157,000 | |
| 7,687,000 | |
| 11,863,000 | |
| 10,159,000 | |
| 8,361,000 | |
| 3,861,000 | |
| 5,488,000 | |
| 0 | |
| 3,361,000 | |
| 3,981,000 | |
| 1,840,000 | |
| 1,414 | |
| 3,137 | |
| 572 | |
| -325,811 | |
| 236,472 | |
| 482,795 | |
| 355,279 |